V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20055238 | 20086632 | 1.78 | 85.5 | null | 2017-12-10 | 2017-12-16 | Capecitabine + Streptozocin | 02 | N | DABRAFENIB + TRAMETINIB | 100979749 |
| 20055283 | 20086633 | 1.81 | 82.5 | Palliative (P) | 2016-06-11 | 2016-06-14 | Abiraterone | 02 | N | IPILIMUMAB + NIVOLUMAB | 101243968 |
| 20055313 | 20086634 | 1.67 | 68 | null | 2019-08-12 | 2019-09-07 | ECarboX | 01 | N | BINIMETINIB + CETUXIMAB + ENCORAFENIB | 101257073 |
| 20055322 | 20086635 | 1.65 | 55 | null | 2019-03-21 | 2019-03-30 | Erlotinib | 02 | N | MIC | 101319871 |
| 20055455 | 20086636 | 1.69 | 58.15 | Adjuvant (A) | 2018-11-21 | 2018-11-25 | Capecitabine + Streptozocin | 02 | N | LENALIDOMIDE | 100745499 |
| 20055504 | 20086638 | null | 59.8 | 03 | 2017-07-21 | 2017-08-05 | CARBOPLATIN + FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100192173 |
| 20055518 | 20086639 | null | null | null | 2016-08-25 | 2016-09-01 | EVEROLIMUS | N | N | EVEROLIMUS | 100695481 |
| 20055522 | 20086640 | 1.46 | 65 | Palliative (P) | 2016-12-08 | 2016-12-24 | NIVOLUMAB | N | N | MITOMYCIN | 101649198 |
| 20055534 | 20086641 | 1.67 | 76 | Palliative (P) | 2019-03-31 | 2019-04-16 | ABC-08 Trial | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100077497 |
| 20055561 | 20086642 | 1.79 | 84.4 | Palliative (P) | 2018-04-11 | 2018-04-17 | Doxorubicin + Olaratumab | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100594887 |
| 20055563 | 20086643 | 0 | 78.1 | Palliative (P) | 2020-05-10 | 2020-05-19 | Gemcitabine + Paclitaxel | 02 | N | STREPTOZOCIN + MDG | 100485597 |
| 20055596 | 20086644 | 1.83 | 52.1 | null | 2017-09-26 | 2017-10-10 | CHOP R - 21 days | 01 | N | GEMCITABINE + PACLITAXEL | 100095275 |
| 20055703 | 20086645 | 1.85 | 46 | Palliative (P) | 2017-09-08 | 2017-09-14 | BCG Intravesical | null | N | ACTICCA-1 TRIAL | 101239416 |
| 20055717 | 20086646 | 1.67 | 33.8 | null | 2019-08-21 | 2019-08-22 | OXALIPLATIN | 02 | N | SCOPE2 TRIAL | 101008936 |
| 20055720 | 20086647 | 1.38 | 76.5 | Palliative (P) | 2019-09-30 | 2019-09-30 | Azacitidine | N | N | PLATO TRIAL | 100599059 |
| 20055747 | 20086648 | null | null | Palliative (P) | null | 2017-11-15 | MITOMYCIN | 01 | N | BENDAMUSTINE + RITUXIMAB | 101667755 |
| 20055850 | 20086650 | 1.67 | 93.7 | Palliative (P) | 2016-08-30 | 2016-08-30 | EVEROLIMUS | 02 | N | ESPAC TRIAL | 100619013 |
| 20055857 | 20086651 | 1.7 | 84 | null | 2018-01-15 | 2018-01-22 | MPV (cycle 1-4) | N | Y | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101013795 |
| 20055884 | 20086652 | 1.77 | 48.9 | Neo-adjuvant (N) | 2016-10-14 | 2016-10-19 | ACELARATE Trial | 02 | N | RALTITREXED | 101526560 |
| 20056005 | 20086653 | null | 71.9 | 03 | 2019-03-26 | 2019-04-16 | Irinotecan | 02 | N | RITUXIMAB | 101603206 |
| 20056018 | 20086654 | 1.63 | 60.3 | Palliative (P) | 2017-04-26 | 2017-05-11 | NIVOLUMAB | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101740259 |
| 20056043 | 20086655 | 0 | 0 | Palliative (P) | 2016-04-29 | 2016-04-29 | Cisplatin + Fluorouracil + RT 5day | N | N | MIC | 101574737 |
| 20056056 | 20086656 | 1.54 | 41.4 | null | 2019-04-19 | 2019-04-19 | PACLITAXEL | 02 | Y | CISPLATIN + FLUOROURACIL + RT | 101725014 |
| 20056070 | 20086657 | 1.74 | 86 | Palliative (P) | 2019-09-03 | 2019-09-04 | EOF | 02 | N | BACILLUS CALMETTE-GUERIN | 101046344 |
| 20056079 | 20086658 | 1.68 | 98 | Palliative (P) | 2016-01-31 | 2016-01-31 | PEMBROLIZUMAB | 02 | Y | LENALIDOMIDE | 101036550 |
| 20056085 | 20086659 | 1.48 | 56.6 | Palliative (P) | 2019-03-28 | 2019-04-12 | PHITT D SIOPEL-4 ( A1, A2, A3) | 02 | N | CARBOPLATIN + FLUOROURACIL | 101753787 |
| 20056098 | 20086660 | 1.86 | 101.8 | null | 2016-07-20 | 2016-08-17 | ACTICCA-1 Trial | 02 | N | GO2 TRIAL | 100274297 |
| 20056134 | 20086661 | 1.65 | 68 | Palliative (P) | 2017-08-27 | 2017-09-10 | PACLITAXEL | 01 | N | TEMOZOLOMIDE | 100853781 |
| 20056155 | 20086662 | null | 75.8 | 03 | 2017-01-19 | 2017-01-27 | Irinotecan | 02 | N | AZACITIDINE | 101396842 |
| 20056172 | 20086663 | 1.67 | 70.6 | 03 | 2018-07-26 | 2018-08-05 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | AZACITIDINE | 101701554 |
| 20056284 | 20086665 | 1.55 | 48.4 | Palliative (P) | 2018-08-25 | 2018-09-07 | CISPLATIN + VINORELBINE | 02 | N | EVEROLIMUS | 101543009 |
| 20056344 | 20086666 | null | 88 | 03 | 2018-10-28 | 2018-10-28 | ACELARATE Trial | 02 | N | EOF | 100972713 |
| 20056394 | 20086667 | 1.84 | 58.7 | Palliative (P) | null | 2018-04-16 | MCX | 02 | N | NIVOLUMAB | 100508416 |
| 20056402 | 20086668 | 1.76 | 48.3 | null | 2018-06-19 | 2018-06-22 | GEMCARBO | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100058327 |
| 20056413 | 20086669 | 1.54 | 93.3 | Curative (C) | null | 2016-10-05 | null | 01 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 101333285 |
| 20056426 | 20086670 | 1.73 | 81 | Palliative (P) | 2020-02-25 | 2020-02-27 | Sunitinib | N | N | DOCETAXEL | 100635586 |
| 20056463 | 20086671 | 1.67 | 86 | Palliative (P) | 2018-05-27 | 2018-05-27 | EVEROLIMUS | 02 | N | FLUOROURACIL + RT | 100780128 |
| 20056511 | 20086673 | 1.72 | 60 | Palliative (P) | 2018-12-27 | 2019-01-20 | Hydroxycarbamide | N | N | OXALIPLATIN | 101581717 |
| 20056516 | 20086674 | 1.68 | 85.8 | null | null | 2018-04-08 | ECarboX | 01 | N | CAPECITABINE + STREPTOZOCIN | 100083180 |
| 20056524 | 20086675 | 1.73 | 75.2 | Palliative (P) | null | 2019-02-07 | PEMBROLIZUMAB | 01 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100877608 |
| 20056578 | 20086676 | 1.97 | 64.3 | Adjuvant (A) | 2018-05-21 | 2018-05-21 | null | N | N | ACELARATE TRIAL | 101797720 |
| 20056591 | 20086677 | null | 7.1 | Palliative (P) | 2016-09-02 | 2016-10-07 | Capecitabine + Streptozocin | 02 | Y | CAPECITABINE + STREPTOZOCIN | 100433520 |
| 20056601 | 20086678 | 1.49 | 54 | null | 2018-12-15 | 2018-12-15 | ARISTOTLE TRIAL | 01 | N | MCX | 100305493 |
| 20056648 | 20086679 | 1.69 | 71.8 | 03 | 2017-02-02 | 2017-02-02 | EEF or EOF | 02 | null | EOF | 101020777 |
| 20056673 | 20086680 | 1.7 | 68.2 | Palliative (P) | 2019-09-08 | 2019-10-01 | Capital Trial | 2 | N | ABIRATERONE | 101519871 |
| 20056722 | 20086681 | 1.65 | 76.8 | Palliative (P) | 2017-05-03 | 2017-05-04 | Rituximab | 02 | Y | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100796319 |
| 20056749 | 20086682 | 1.73 | 58 | Palliative (P) | 2017-09-06 | 2017-09-24 | Sunitinib | 02 | N | ACELARATE TRIAL | 100567104 |
| 20056755 | 20086683 | 1.65 | null | Palliative (P) | 2016-12-21 | 2016-12-31 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | OXALIPLATIN | 101761519 |
| 20056776 | 20086684 | null | null | Palliative (P) | 2019-07-21 | 2019-07-21 | EOF | 02 | N | NAB-PACLITAXEL | 101533361 |
| 20056782 | 20086685 | null | null | null | 2016-12-29 | 2017-01-24 | GO2 TRIAL | N | N | PACLITAXEL | 101639766 |